Roy Buchanan Stock Analyst Profile - JMP Securities Research Coverage - Stocknear

Roy Buchanan

Stock Analyst at JMP Securities

(5)
# 276
Out of 5,478 analysts
79
Total ratings
Success rate
Average return
18 Stocks
Name Action PT Current % Upside Ratings Updated
DVAX Dynavax Technologies
Reiterates: Market Outperform
32 32
9.41 240.06% 8 Aug 22, 2025
ENTA Enanta Pharma
Maintains: Market Outperform
24 25
8.28 201.93% 15 Aug 12, 2025
CDTX Cidara Therapeutics
Maintains: Market Outperform
59 66
65.62 0.58% 7 Aug 8, 2025
PYPD PolyPid
Maintains: Market Outperform
16 14
3.47 303.46% 2 Jun 17, 2025
CVAC CureVac
Reiterates: Market Outperform
10 10
5.34 87.27% 9 May 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
5 2
1.26 58.73% 9 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
18 18
2.38 656.3% 3 Mar 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Perform
n/a
n/a n/a 1 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
7 4
2.84 40.85% 3 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
23 14
1.31 968.7% 1 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
33 33
84.01 -60.72% 1 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
24 7
n/a n/a 2 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 5 Oct 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
4 5
4.46 12.11% 5 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 3 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
443 448
756.38 -40.77% 2 Mar 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
14 16
12.94 23.65% 1 Mar 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Feb 16, 2023